AI is part of every aspect of the life sciences ecosystem - from understanding new targets of disease and development of therapeutics to the diagnosis, prognosis and management of disease. Protecting these innovations requires a complex overlay of patents and trade secrets. During this session from the Everything from Everywhere Virtual Summit, Womble Bond Dickinson Partner Karthika Perumal, Ph.D., discussed what 2021 holds with respect to these different types of IP for AI innovations.